Renaissance Capital logo

Sarissa Capital Acquisition Priced, Nasdaq: SRSAU

Blank check company formed by Sarissa Capital focused on healthcare and biopharma.

Industry: SPAC

Latest Trade: $10.00 0.00 (0.0%)

First Day Return: +2.3%

Return from IPO: 0.0%

Industry: SPAC

We are a newly incorporated blank check company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. While we may pursue an acquisition opportunity in any business, industry, sector or geographical location, we intend to focus on industries that complement our management team’s background, and to capitalize on the ability of our management team to identify and acquire a business, focusing on the healthcare and biopharma industry. We may pursue a transaction in which our shareholders immediately prior to the completion of our initial business combination would collectively own a minority interest in the post-business combination company. Our officers and directors have extensive experience in identifying, negotiating with and conducting due diligence on companies targeted for acquisition and consummating acquisitions of healthcare and biopharma companies. Our management team, however, does not have prior experience in pursuing acquisitions on behalf of blank check companies and past performance by our management team is not a guarantee of success with respect to locating a target business to acquire.
more less
IPO News for Sarissa Capital Acquisition
more
IPO Data
IPO File Date 09/30/2020
Offer Price $10.00
Price Range $10.00 - $10.00
Offer Shares (mm) 17.5
Deal Size ($mm) $175
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 10/20/2020
Offer Price $10.00
Price Range $10.00 - $10.00
Offer Shares (mm) 17.5
Deal Size ($mm) $175
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
Underwriters
more
Company Data
Headquarters Greenwich, CT
Founded 2020
Employees 6
Website www.sarissacap.com